CenExel Clinical Research Announces the Acquisition of iResearch

CenExel Clinical Research has announced their acquisition of iResearch, a leading multi-specialty research site business. iResearch is known for their expertise in and experience in conducting clinical studies including Phase I-IV. This experience includes more than 200 clinical trials in both inpatient and outpatient settings.

This acquisition is poised to strengthen CenExel’s leading central nervous system (CNS) trial capabilities in both psychiatry and neurology therapeutic areas. 

Now called CenExel iResearch, the company operates in a state-of-the-art clinical research facility with a 10,000 sq ft inpatient unit. CenExel iResearch is led by co-founders Heather Beitz and Sara Castle, who serve as CEO and COO, respectively. Dr. Kimball Johnson serves as the organization’s Medical Director, with 30+ years of experience, as part of the CenExel iResearch team of 10 principal investigators. Zach Mitchell serves as the organization’s Director of Business Development, leading both sales and strategic operations, and will serve in a similar capacity with CenExel iResearch moving forward.

CenExel iResearch will benefit from CenExel’s extensive network which offers fully integrated and collaborative processes from centralized budgeting, business development, quality management and more.

CenExel was formed in 2018, and since its formation, has strategically invested to support organic growth in its centers of excellence, while also pursuing acquisitions of state-of-the-art research centers across the U.S. The mission of CenExel is to work with trial Sponsors and Contract Research Organizations to drive efficiencies in clinical research, while reducing the costs and development timelines for innovative therapies to advance patient care.

Are you developing new software for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Recent Posts